Clinical Trials Logo

Clinical Trial Summary

Background: Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the function of other tissues in the body. Researchers want to study people who may have endocrine disorders. They want to learn more about the conditions that affect endocrine glands. Objective: To study adults with a variety of endocrine disorders for research and physician education. Eligibility: Adults ages 18 and older who have an endocrine or metabolic-related disorder Healthy volunteers 18 and older Design: Participants will be screened with a review of their medical records. Participants will have a physical exam and medical history. The length of the study and the schedule will vary by participant. Tests may include: Blood and urine tests Stool and saliva samples Imaging studies: Participants will lie on a table while a machine takes pictures of the body. They may be injected with a substance to make their organs more visible in the pictures. Tests of endocrine tissue function Consultation with other specialists Sleep study Medical photographs Participants may be treated for their endocrine disorder. This could include: Surgery. If tissue is removed during surgery, it may be studied. Radiation Medicine Participants may have genetic testing. This will be done with a small amount of blood, cells from a cheek swab, or saliva. Sponsoring Institution: National Institute of Digestive, Diabetes and Kidney Disease


Clinical Trial Description

This protocol is designed to allow inpatient and outpatient evaluation of adults with a variety of endocrine disorders for purposes of research and physician education in our accredited internal medicine endocrinology training programs. Participants will receive clinical care per standard of practice for their condition. Data collected from standard clinical practice will be retained for future research. The research-directed evaluations may include collection and retention for future use of blood, feces, saliva, or urine samples or evaluation of tissue that was routinely collected for clinical care. In some patients with endocrine disorders, laboratory or radiological studies will be performed to confirm a diagnosis or to aid in the management of the patient, using standard approaches in current clinical practice. In some cases, the patient will receive medical, radiation or surgical treatment for their disorder. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03867448
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact Raven N McGlotten, R.N.
Phone (301) 827-0190
Email mcglottenr@mail.nih.gov
Status Recruiting
Phase
Start date March 27, 2019
Completion date January 1, 2036

See also
  Status Clinical Trial Phase
Recruiting NCT03050762 - Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
Completed NCT01419535 - Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults Phase 1/Phase 2
Completed NCT00001849 - New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome Phase 2
Terminated NCT00001850 - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Recruiting NCT00004847 - Diagnosis of Pheochromocytoma Phase 1
Active, not recruiting NCT03014882 - Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? Phase 1/Phase 2
Completed NCT01735617 - Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH Phase 2
Recruiting NCT01511588 - Hormonal Regulation of Puberty and Fertility